(Q35678588)

9 August 2017

1 reference

title

Magnesium disorders and cardiovascular diseases (English)

1 reference

9 August 2017

main subject

cardiovascular disease

1 reference

Purvis JR

1

1 reference

9 August 2017

Movahed A

series ordinal

2

1 reference

9 August 2017

publication date

1 August 1992

1 reference

9 August 2017

1 reference

9 August 2017

volume

15

1 reference

9 August 2017

issue

8

1 reference

9 August 2017

page(s)

556-568

1 reference

Minerals, Coronary Heart Disease and Sudden Coronary Death1,2

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

The Water Factor and Mortality from Ischemic Heart Disease: A Review and Possible Explanations for Inconsistent Findings with Additional Data from Manitoba

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

Hypertension and peripheral insulin resistance. Possible mediating role of intracellular free magnesium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

Magnesium and lipids in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

Magnesium and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

Hypothesis: increased calcium and decreased magnesium in heart muscle and liver of pigs dying suddenly of microangiopathy (mulberry heart disease): an animal model for the study of oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

Antiarrhythmic short-term protective magnesium treatment in ischemic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

Magnesium deficiency in coronary artery disease and cardiac arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

Magnesium and cardiac arrhythmias: nutrient or drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

The ionic basis of the anti-ischemic and anti-arrhythmic properties of magnesium in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

Treatment of torsade de pointes with magnesium sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations--magnesium and chloride loss in refractory potassium repletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Calcium, magnesium, and phosphorus balance in human and experimental hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Low blood mononuclear cell magnesium in intensive cardiac care unit patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium Deficiency in Patients on Long-Term Diuretic Therapy for Heart Failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium ions in cardiac function. Regulator of ion channels and second messengers

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Serum parameters in hard and soft water communities

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Changes in water hardness and local death-rates

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Water hardness, arteriosclerotic heart disease and sudden death

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Risk of myocardial infarction in Finnish men in relation to fluoride, magnesium and calcium concentration in drinking water

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Relationship of metal metabolism to vascular disease mortality rates in Texas

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Clinical and biochemical indicators of cardiovascular disease among men living in hard and soft water areas

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Soft Water, Heart Attacks, and Stroke

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Prevalence and pathological changes of ischaemic heart-disease in a hard-water and in a soft-water area

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

https://api.crossref.org/works/10.1002%2FCLC.4960150804

1 reference

7 January 2021

The role of chemical constituents of drinking water in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Risk of sudden death in soft water areas

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

CORRELATIONS BETWEEN WATER HARDNESS AND CARDIOVASCULAR DEATHS IN OKLAHOMA COUNTIES.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Mortality and water-hardness in three matched communities in Los Angeles

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Water hardness and cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Water hardness and heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

The importance of magnesium deficiency in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium interrelationships in ischemic heart disease: a review

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Heart-muscle magnesium, potassium, and zinc concentrations after sudden death from heart-disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Myocardial tissue concentrations of magnesium and potassium in men dying suddenly from ischemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium deficiency in patients with ischemic heart disease with and without acute myocardial infarction uncovered by an intravenous loading test

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium deficiency detected by intravenous loading test in variant angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Influence of dietary magnesium on cardiac and renal lesions of young rats fed an atherogenic diet

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Interrelationships between experimental hypercholesteremia, magnesium requirement, and experimental atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Prophylactic treatment of an experimental arteriosclerosis with magnesium and potassium salts

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Effects of Dietary Magnesium and Glycyrrhizin on Experimental Atheromatosis of Rats (Long-Term Experiment)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Effect of dietary magnesium on development of atherosclerosis in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Protective effects of dietary calcium and magnesium on platelet function and atherosclerosis in rabbits fed saturated fat

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Hypertension and abnormal glucose homeostasis. Possible role of divalent ion metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium levels of plasma, erythrocyte and urine in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium deficiency in IDDM related to level of glycosylated hemoglobin

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Hypomagnesemia, a risk factor in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Tissue magnesium status in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

The Effect of Calcium and Magnesium on Glucagon Secretion*

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

The Effect of Magnesium Deficiency on Glucose Stimulated Insulin Secretion in Rats

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

The action of insulin on glucose uptake by isolated rat soleus muscle. I. Effects of cations

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Effects of insulin on vasoconstriction induced by thromboxane A2 in porcine coronary artery

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Correlation of serum-magnesium and serum-cholesterol levels in South African Bantu and European subjects

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Reduction of plasma lecithin--cholesterol acyltransferase activity by acute magnesium deficiency in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Effect of Magnesium Deficiency on Lipid Metabolism in Rats Fed a High Carbohydrate Diet

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Metabolic effects of a low-magnesium diet in pigs

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium-lipid relations in health and in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Treatment of hypercholesterolaemia and hypertriglyceridaemia with magnesium

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium: Nature's physiologic calcium blocker

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Four urinary cations and blood pressure. A population study in two Belgian towns

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Monovalent and divalent cations in hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Calcium and magnesium nutrition in human hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Increased erythrocyte magnesium content in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Serum magnesium and plasma sodium levels in essential vascular hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Changes in calcium and magnesium metabolism in essential arterial hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Calcium and magnesium in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium and blood pressure: review of the epidemiologic and clinical trial experience

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Relation of serum and erythrocyte magnesium levels to blood pressure and a family history of hypertension. A follow-up study in Japanese children, 12-14 years old.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Oral magnesium supplementation in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Renin, calcium metabolism and the pathophysiologic basis of antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Thiazide treatment of systemic hypertension: effects on serum magnesium and ventricular ectopic activity

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium depletion in patients on long-term chlorthalidone therapy for essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium deficiency in two hypertensive patient groups

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

The metabolic effects of thiazide therapy in the elderly: a population study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Intracellular magnesium loss after diuretic administration

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Effect of magnesium on blood pressure.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Intracellular magnesium deficiency and effect of oral magnesium on blood pressure and red cell sodium transport in diuretic-treated hypertensive patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Type-A behavior and coronary vasospasm: a possible role of hypomagnesemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Leucocyte and erythrocyte magnesium levels after jejuno-ileal bypass surgery

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Potassium, magnesium, and calcium balance in obese adolescents on a protein-sparing modified fast

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Intracellular electrolytes and lipid metabolism in obesity

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Is verapamil a better magnesium agonist rather than a calcium antagonist? A hypothesis?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Effects of magnesium on the tone of isolated human coronary arteries. Comparison with diltiazem and nitroglycerin

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium administration reduces platelet hyperaggregability in NIDDM

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Beneficial effect of magnesium sulfate in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Serum magnesium levels in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Serum magnesium in acute myocardial infarction. Relation to arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Serum magnesium and copper levels in myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

A comparison of plasma magnesium values in patients with acute myocardial infarction and patients with chest pain due to other causes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Serum Magnesium and Potassium in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium, myocardial ischaemia and arrhythmias. The role of magnesium in myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Serum, lymphocyte, and erythrocyte potassium, magnesium, and calcium concentrations and their relation to tachyarrhythmias in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

The cardiomyopathy of hypoparathyroidism. Another reversible form of heart muscle disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

A geochemical basis for endomyocardial fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Endomyocardial fibrosis--the possible connexion with myocardial levels of magnesium and cerium

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium and Potassium Metabolism in Patients with Idiopathic Cardiomyopathy and Chronic Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium deficiency in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Renal excretion of electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Diuretics and intracellular cations

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Importance of magnesium in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Sudden unexpected death in patients with congestive heart failure: a second frontier

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Effects of enalapril on lymphocyte sodium, potassium, magnesium and calcium levels in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Prognostic importance of the serum magnesium concentration in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium and congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Role of magnesium in cardiac tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Suppression of ventricular arrhythmias by magnesium

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Does exogenous magnesium suppress myocardial irritability and tachyarrhythmias in the nondigitalized patient?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium treatment of ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Relation between potassium, magnesium and cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Effects of low potassium or magnesium concentrations on isolated cardiac tissue

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium-induced bradycardia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Potassium/magnesium depletion in patients with cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium depletion, diuretics, and arrhythmias.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Hypomagnesium in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Hypomagnesemia and refractory cardiac arrhythmia in a nondigitalized patient

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium deficiency and cardiac disorders

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Rapid bolus magnesium sulfate for supraventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Serum and tissue magnesium concentrations in patients with heart failure and serious ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Efficacy of magnesium sulfate in the treatment of torsade de pointes.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium therapy for torsades de pointes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Limited effect of magnesium sulphate on torsades de pointes ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium in Cardiac Arrhythmia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium and potassium therapy in multifocal atrial tachycardia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Effect of intravenous magnesium sulfate on supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Frequency of hypomagnesemia in hospitalized patients receiving digitalis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Effect of magnesium chloride on electrical stability of the heart

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Oral magnesium reduces ventricular ectopy in digitalised patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Hypomagnesemia in relation to digoxin intoxication in children

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium sulfate and digitalis-toxic arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Studies on magnesium's mechanism of action in digitalis-induced arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium sulfate in digitalis toxicity.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Correlation of serum magnesium levels and cardiac digitalis intoxication

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Magnesium therapy in massive digoxin intoxication

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Acute digitalis poisoning: the role of intravenous magnesium sulfate

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Management of magnesium depletion

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Hemodynamic effects of intravenously administered magnesium on patients with ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150804

7 January 2021

Identifiers

DOI

10.1002/CLC.4960150804

1 reference

release_475nav35q5dqrn4vtisgd4m4cm

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/475nav35q5dqrn4vtisgd4m4cm

24 November 2022

mapped directly with Wikidata item

1 reference